Ophthalmology
Volume 118, Issue 3 , Pages 459-467 , March 2011

Randomized Evaluation of the Trabecular Micro-Bypass Stent with Phacoemulsification in Patients with Glaucoma and Cataract

Presented at: the American Academy of Ophthalmology 2009 Annual meeting, October 2009, San Francisco, California; and in part at the American Society of Cataract and Refractive Surgery 2010 Annual Meeting, April 2010, Boston, Massachusetts.

  • Thomas W. Samuelson, MD

      Affiliations

    • Minnesota Eye Consultants, Minneapolis, Minnesota
  • ,
  • L. Jay Katz, MD

      Affiliations

    • Wills Eye Hospital, Philadelphia, Pennsylvania
  • ,
  • Jeffrey M. Wells, PharmD

      Affiliations

    • Glaukos Corporation, Laguna Hills, California
  • ,
  • Yi-Jing Duh, PhD

      Affiliations

    • ClinReg Consulting, Inc., Laguna Beach, California
  • ,
  • Jane Ellen Giamporcaro, BS

      Affiliations

    • Glaukos Corporation, Laguna Hills, California
    • Corresponding Author InformationCorrespondence: Jane Ellen Giamporcaro, BS, Glaukos Corp., 26051 Merit Circle #103, Laguna Hills, CA 92653
  • ,
  • US iStent Study Group

Received 19 December 2009 ,Revised 1 July 2010 ,Accepted 7 July 2010.

References 

  1. Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532–538
  2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267
  3. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–851
  4. Kass MA, Heuer DK, Higginbotham EJ, et al. Ocular Hypertension Treatment Study Group: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713
  5. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-Up Study: 7. Results. Am J Ophthalmol. 1995;120:718–731
  6. Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953
  7. Kass MA, Gordon M, Morley RE, et al. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103:188–193
  8. Robin AL, Novack GD, Covert DW, et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533–540
  9. Stone JL, Robin AL, Novack GD, et al. An objective evaluation of eye-drop instillation in glaucoma patients. Arch Ophthalmol. 2009;127:732–736
  10. Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43:454–461
  11. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol. 2004;137(suppl):S3–S12
  12. Covert D, Robin AL, Novack GD. Systemic medications and glaucoma patients (letter). Ophthalmology. 2005;112:1849–3
  13. Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology. 2008;115:109–115
  14. Realini T. Selective laser trabeculoplasty: a review. J Glaucoma. 2008;17:497–502
  15. AGIS Investigators. The advanced glaucoma intervention study, 8: risk of cataract formation after trabeculectomy. Arch Ophthalmol. 2001;119:1771–1779
  16. De Bry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297–300
  17. Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond). 2002;16:297–303
  18. Parrish R, Sternberg P. Does “Off-Label” mean off limits for patient care?. Am J Ophthalmol. 2007;143:853–855
  19. Tennen DG, Masket S. Short-and long-term effect of clear corneal incisions on intraocular pressure. J Cataract Refract Surg. 1996;22:568–570
  20. Shingleton BJ, Gamell LS, O'Donoghue MW, et al. Long-term changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg. 1999;25:885–890
  21. Shingleton BJ, Pasternack JJ, Hung JW, O'Donoghue MW. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006;15:494–498
  22. Kim DD, Doyle JW, Smith MF. Intraocular pressure reduction following phacoemulsification cataract extraction with posterior chamber lens implantation in glaucoma patients. Ophthalmic Surg Lasers. 1999;30:37–40
  23. Hayashi K, Hayashi H, Nakao F, Hayashi F. Effect of cataract surgery on intraocular pressure control in glaucoma patients. J Cataract Refract Surg. 2001;27:1779–1786
  24. Poley BJ, Lindstrom RL, Samuelson TW. Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg. 2008;34:735–742
  25. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783–801
  26. Johnstone MA, Grant WG. Pressure-dependent changes in structures of the aqueous outflow system of human and monkey eyes. Am J Ophthalmol. 1973;75:365–383
  27. Rosenquist R, Epstein D, Melamed S, et al. Outflow resistance of enucleated human eyes at two different perfusion pressures and different extents of trabeculotomy. Curr Eye Res. 1989;8:1233–1240
  28. Spiegel D, Kobuch K. Trabecular meshwork bypass tube shunt: initial case series. Br J Ophthalmol. 2002;86:1228–1231
  29. Zhou J, Smedley GT. A trabecular bypass flow hypothesis. J Glaucoma. 2005;14:74–83
  30. Bahler CK, Smedley GT, Zhou J, Johnson DH. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthalmol. 2004;138:988–994
  31. Spiegel D, Wetzel W, Haffner DS, Hill RA. Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma. Adv Ther. 2007;24:161–170
  32. Spiegel D, Garcia-Feijoo J, Garcia-Sanchez J, Lamielle H. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther. 2008;25:453–464
  33. Spiegel D, Wetzel W, Neuhann T, et al. Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol. 2009;19:393–399
  34. Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg. 2010;36:407–412
  35. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999;117:573–583
  36. Singh K, Lee BL, Wilson MR Glaucoma Modified RAND-Like Methodology Group. A panel assessment of glaucoma management: modification of existing RAND-like methodology for consensus in ophthalmology (Part II: Results and interpretation). Am J Ophthalmol. 2008;145:575–581
  37. Schwenn O, Yun SH, Troost A, Pfeiffer N. Glaucoma studies from 1996 to 1999 in peer-reviewed journals. Graefes Arch Clin Exp Ophthalmol. 2005;243:629–636
  38. Luttrull JK, Avery RL, Baerveldt G, Easley KA. Initial experience with pneumatically stented Baerveldt implant modified for pars plana insertion for complicated glaucoma. Ophthalmology. 2000;107:143–149
  39. Burgoyne JK, WuDunn D, Lakhani V, Cantor LB. Outcomes of sequential tube shunts in complicated glaucoma. Ophthalmology. 2000;107:309–314
  40. Scott IU, Gedde SJ, Budenz DL, et al. Baerveldt drainage implants in eyes with a preexisting scleral buckle. Arch Ophthalmol. 2000;118:1509–1513
  41. Hoffman KB, Feldman RM, Budenz DL, et al. Combined cataract extraction and Baerveldt glaucoma drainage implant: indications and outcomes. Ophthalmology. 2002;109:1916–1920
  42. Roy S, Ravinet E, Mermoud A. Baerveldt implant in refractory glaucoma: long-term results and factors influencing outcome. Int Ophthalmol. 2002;24:93–100
  43. Harbick KH, Sidoti PA, Budenz DL, et al. Outcomes of inferonasal Baerveldt glaucoma drainage implant surgery. J Glaucoma. 2006;15:7–12
  44. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern (Primary Open-Angle Glaucoma). http://one.aao.org/CE/PracticeGuidelines/PPP.aspxSan Francisco, CA: American Academy of Ophthalmology; 2005;12, Accessed May 15, 2010
  45. Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg. 2007;33:1217–1226
  46. Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results. J Cataract Refract Surg. 2009;35:814–824
  47. Shields MB, inventor; Yale University, assignee. Uveoscleral drainage device. US Patent 7,041,077. May 9, 2005.

 Manuscript no. 2009-1734.

 Financial Disclosure(s): The author(s) have made the following disclosure(s): TWS: C, O to Glaukos, and C to Alcon, Allergan, AMO, AqueSys, iScience, Ivantis, Pfizer, QLT, and Santen. LJK: C, O to Glaukos, C to Allergan, Alcon, Pfizer, and Lumenis; JW: E, O to Glaukos; Y-JD: C, O to Glaukos and C to Ivantis; JEG: E, O to Glaukos. All the investigators were consultants to Glaukos for the conduct of this study. In addition, Drs. Bacharach, Buznego, Cantor, and Nichamin are equity owners of Glaukos.

 Funding: Glaukos Corp.

 This study was registered with clinicaltrials.gov as NCT00323284.

PII: S0161-6420(10)00743-8

doi: 10.1016/j.ophtha.2010.07.007

Ophthalmology
Volume 118, Issue 3 , Pages 459-467 , March 2011